Clinical trial
The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
NCT01814943 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- May 31, 2013
- Enrollment
- 39,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
uncomplicated peptic ulcer